Sorafenib Induced Complete Cytogenetic and Molecular Response in a Chronic Eosinophilic Leukemia Case with t(12;13) Translocation
Clin Hematol Int
.
2020 Jul 27;2(3):129-131.
doi: 10.2991/chi.k.200714.001.
eCollection 2020 Sep.
Authors
Federica Ricci
1
,
Serena Balducci
1
,
Francesca Guerrini
1
,
Susanna Grassi
1
,
Elena Ciabatti
1
,
Claudia Baratè
2
,
Maria Immacolata Ferreri
3
,
Cecilia Giuliani
3
,
Angelo Valetto
3
,
Mario Petrini
1
,
Sara Galimberti
1
Affiliations
1
Department of Clinical and Experimental Medicine, UO Hematology, University of Pisa, Pisa, Italy.
2
UO Hematology, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
3
UO Cytogenetics, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
PMID:
34595453
PMCID:
PMC8432331
DOI:
10.2991/chi.k.200714.001
No abstract available
Keywords:
Chronic eosinophilic leukemia; ETV6/FLT3; Sorafenib; t(12;13).